Nuvectis Pharma, Inc. (NVCT)
7.78
-0.20
(-2.51%)
USD |
NASDAQ |
Dec 19, 16:00
7.82
+0.04
(+0.51%)
After-Hours: 20:00
Nuvectis Pharma EPS Diluted (Quarterly): -0.4354 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.891M |
| Total Expenses (Quarterly) | 9.891M |
| Enterprise Value | 163.84M |
| Earnings Yield | -16.96% |
| Normalized Earnings Yield | -16.96 |